Cite
HARVARD Citation
McInerney, C. et al. (n.d.). BTC1.04 Genomic profiling of IDH-wildtype and IDH-mutant initial and matched recurrent glioblastomas reveals clinically actionable mutations (e.g. BRCA1/2) and resistance signatures. Neuro-oncology. pp. iii215-iii216. [Online].